Is tau ready for admission to the prion club?

References

• Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216:136 - 44; http://dx.doi.org/10.1126/science.6801762; PMID: 6801762
   PubMed Web of Science ®Google Scholar
• Prusiner SB, Bolton DC, Groth DF, Bowman KA, Cochran SP, McKinley MP. Further purification and characterization of scrapie prions. Biochemistry 1982; 21:6942 - 50; http://dx.doi.org/10.1021/bi00269a050; PMID: 6818988
   PubMed Web of Science ®Google Scholar
• Büeler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, et al. Mice devoid of PrP are resistant to scrapie. Cell 1993; 73:1339 - 47; http://dx.doi.org/10.1016/0092-8674(93)90360-3; PMID: 8100741
   PubMed Web of Science ®Google Scholar
• Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991; 82:239 - 59; http://dx.doi.org/10.1007/BF00308809; PMID: 1759558
   PubMed Web of Science ®Google Scholar
• Braak H, Ghebremedhin E, Rüb U, Bratzke H, Del Tredici K. Stages in the development of Parkinson’s disease-related pathology. Cell Tissue Res 2004; 318:121 - 34; http://dx.doi.org/10.1007/s00441-004-0956-9; PMID: 15338272
   PubMed Web of Science ®Google Scholar
• Armstrong RA, Cairns NJ, Lantos PL. What does the study of the spatial patterns of pathological lesions tell us about the pathogenesis of neurodegenerative disorders?. Neuropathology 2001; 21:1 - 12; http://dx.doi.org/10.1046/j.1440-1789.2001.00373.x; PMID: 11304036
   PubMed Web of Science ®Google Scholar
• Su JH, Deng G, Cotman CW. Transneuronal degeneration in the spread of Alzheimer’s disease pathology: immunohistochemical evidence for the transmission of tau hyperphosphorylation. Neurobiol Dis 1997; 4:365 - 75; http://dx.doi.org/10.1006/nbdi.1997.0164; PMID: 9440125
   PubMed Web of Science ®Google Scholar
• Giasson BI, Forman MS, Higuchi M, Golbe LI, Graves CL, Kotzbauer PT, et al. Initiation and synergistic fibrillization of tau and alpha-synuclein. Science 2003; 300:636 - 40; http://dx.doi.org/10.1126/science.1082324; PMID: 12714745
   PubMed Web of Science ®Google Scholar
• Laurén J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 2009; 457:1128 - 32; http://dx.doi.org/10.1038/nature07761; PMID: 19242475
   PubMed Web of Science ®Google Scholar
• Giaccone G, Mangieri M, Capobianco R, Limido L, Hauw JJ, Haïk S, et al. Tauopathy in human and experimental variant Creutzfeldt-Jakob disease. Neurobiol Aging 2008; 29:1864 - 73; http://dx.doi.org/10.1016/j.neurobiolaging.2007.04.026; PMID: 17560687
   PubMed Web of Science ®Google Scholar
• Clinton LK, Blurton-Jones M, Myczek K, Trojanowski JQ, LaFerla FM. Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline. J Neurosci 2010; 30:7281 - 9; http://dx.doi.org/10.1523/JNEUROSCI.0490-10.2010; PMID: 20505094
   PubMed Web of Science ®Google Scholar
• Haïk S, Privat N, Adjou KT, Sazdovitch V, Dormont D, Duyckaerts C, et al. Alpha-synuclein-immunoreactive deposits in human and animal prion diseases. Acta Neuropathol 2002; 103:516 - 20; http://dx.doi.org/10.1007/s00401-001-0499-z; PMID: 11935269
   PubMed Web of Science ®Google Scholar
• Novak P, Prcina M, Kontsekova E. Tauons and prions: infamous cousins?. J Alzheimers Dis 2011; 26:413 - 30; PMID: 21694453
   PubMed Web of Science ®Google Scholar
• Cushman M, Johnson BS, King OD, Gitler AD, Shorter J. Prion-like disorders: blurring the divide between transmissibility and infectivity. J Cell Sci 2010; 123:1191 - 201; http://dx.doi.org/10.1242/jcs.051672; PMID: 20356930
   PubMed Web of Science ®Google Scholar
• Hall GF. What is the common link between protein aggregation and interneuronal lesion propagation in neurodegenerative disease? in “Neurodegenerative Diseases - Processes, Prevention, Protection and Monitoring”,2011 R. Chang ed. InTech pp 1-17.
   Google Scholar
• Aguzzi A, Rajendran L. The transcellular spread of cytosolic amyloids, prions, and prionoids. Neuron 2009; 64:783 - 90; http://dx.doi.org/10.1016/j.neuron.2009.12.016; PMID: 20064386
   PubMed Web of Science ®Google Scholar
• Moreno-Gonzalez I, Soto C. Misfolded protein aggregates: mechanisms, structures and potential for disease transmission. Semin Cell Dev Biol 2011; 22:482 - 7; http://dx.doi.org/10.1016/j.semcdb.2011.04.002; PMID: 21571086
   PubMed Web of Science ®Google Scholar
• Brundin P, Melki R, Kopito R. Prion-like transmission of protein aggregates in neurodegenerative diseases. Nat Rev Mol Cell Biol 2010; 11:301 - 7; http://dx.doi.org/10.1038/nrm2873; PMID: 20308987
   PubMed Web of Science ®Google Scholar
• Kim W, Lee S, Jung C, Ahmed A, Lee G, Hall GF. Interneuronal transfer of human tau between Lamprey central neurons in situ. J Alzheimers Dis 2010; 19:647 - 64; PMID: 20110609
   PubMed Web of Science ®Google Scholar
• Kim W, Lee S, Hall GF. Secretion of human tau fragments resembling CSF-tau in Alzheimer’s disease is modulated by the presence of the exon 2 insert. FEBS Lett 2010; 584:3085 - 8; http://dx.doi.org/10.1016/j.febslet.2010.05.042; PMID: 20553717
   PubMed Web of Science ®Google Scholar
• Saman S, Kim W, Raya M, Visnick Y, Miro S, Saman S, et al. Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease. J Biol Chem 2012; 287:3842 - 9; http://dx.doi.org/10.1074/jbc.M111.277061; PMID: 22057275
   PubMed Web of Science ®Google Scholar
• Lee S, Kim W, Li Z, Hall GF. Accumulation of vesicle-associated human tau in distal dendrites drives degeneration and tau secretion in an in situ cellular tauopathy model. In “Animal Models of Alzheimer's Disease” Journal of Alzheimer’s Disease 2011. in press Hindawi ISBN: 978-953-307-797-0.
   Google Scholar
• Yamada K, Cirrito JR, Stewart FR, Jiang H, Finn MB, Holmes BB, et al. In vivo microdialysis reveals age-dependent decrease of brain interstitial fluid tau levels in P301S human tau transgenic mice. J Neurosci 2011; 31:13110 - 7; http://dx.doi.org/10.1523/JNEUROSCI.2569-11.2011; PMID: 21917794
   PubMed Web of Science ®Google Scholar
• Frost B, Jacks RL, Diamond MI. Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem 2009; 284:12845 - 52; http://dx.doi.org/10.1074/jbc.M808759200; PMID: 19282288
   PubMed Web of Science ®Google Scholar
• Hall GF, Lee S, Yao J. Neurofibrillary degeneration can be arrested in an in vivo cellular model of human tauopathy by application of a compound which inhibits tau filament formation in vitro. J Mol Neurosci 2002; 19:253 - 60; http://dx.doi.org/10.1385/JMN:19:3:251; PMID: 12540050
   PubMed Web of Science ®Google Scholar
• Clavaguera F, Bolmont T, Crowther RA, Abramowski D, Frank S, Probst A, et al. Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 2009; 11:909 - 13; http://dx.doi.org/10.1038/ncb1901; PMID: 19503072
   PubMed Web of Science ®Google Scholar
• Gómez-Ramos A, Díaz-Hernández M, Cuadros R, Hernández F, Avila J. Extracellular tau is toxic to neuronal cells. FEBS Lett 2006; 580:4842 - 50; http://dx.doi.org/10.1016/j.febslet.2006.07.078; PMID: 16914144
   PubMed Web of Science ®Google Scholar
• Alper T, Cramp WA, Haig DA, Clarke MC. Does the agent of scrapie replicate without nucleic acid?. Nature 1967; 214:764 - 6; http://dx.doi.org/10.1038/214764a0; PMID: 4963878
   PubMed Web of Science ®Google Scholar
• Gajdusek DC, Gibbs CJ, Alpers M. Experimental transmission of a Kuru-like syndrome to chimpanzees. Nature 1966; 209:794 - 6; http://dx.doi.org/10.1038/209794a0; PMID: 5922150
   PubMed Web of Science ®Google Scholar
• Maddelein ML, Wickner RB. Two prion-inducing regions of Ure2p are nonoverlapping. Mol Cell Biol 1999; 19:4516 - 24; PMID: 10330190
   PubMed Web of Science ®Google Scholar
• Masison DC, Wickner RB. Prion-inducing domain of yeast Ure2p and protease resistance of Ure2p in prion-containing cells. Science 1995; 270:93 - 5; http://dx.doi.org/10.1126/science.270.5233.93; PMID: 7569955
   PubMed Web of Science ®Google Scholar
• Kabani M, Melki R. Yeast prions assembly and propagation: Contributions of the prion and non-prion moieties and the nature of assemblies. Prion 2011; 5; http://dx.doi.org/10.4161/pri.5.4.18070; PMID: 22052349
   PubMed Web of Science ®Google Scholar
• Tuite MF, Serio TR. The prion hypothesis: from biological anomaly to basic regulatory mechanism. Nat Rev Mol Cell Biol 2010; 11:823 - 33; http://dx.doi.org/10.1038/nrm3007; PMID: 21081963
   PubMed Web of Science ®Google Scholar
• Ross ED, Edskes HK, Terry MJ, Wickner RB. Primary sequence independence for prion formation. Proc Natl Acad Sci U S A 2005; 102:12825 - 30; http://dx.doi.org/10.1073/pnas.0506136102; PMID: 16123127
   PubMed Web of Science ®Google Scholar
• Tanaka M, Chien P, Naber N, Cooke R, Weissman JS. Conformational variations in an infectious protein determine prion strain differences. Nature 2004; 428:323 - 8; http://dx.doi.org/10.1038/nature02392; PMID: 15029196
   PubMed Web of Science ®Google Scholar
• Legname G, Nguyen HO, Baskakov IV, Cohen FE, Dearmond SJ, Prusiner SB. Strain-specified characteristics of mouse synthetic prions. Proc Natl Acad Sci U S A 2005; 102:2168 - 73; http://dx.doi.org/10.1073/pnas.0409079102; PMID: 15671162
   PubMed Web of Science ®Google Scholar
• Nilsson KP, Joshi-Barr S, Winson O, Sigurdson CJ. Prion strain interactions are highly selective. J Neurosci 2010; 30:12094 - 102; http://dx.doi.org/10.1523/JNEUROSCI.2417-10.2010; PMID: 20826672
   PubMed Web of Science ®Google Scholar
• Gambetti P, Cali I, Notari S, Kong Q, Zou WQ, Surewicz WK. Molecular biology and pathology of prion strains in sporadic human prion diseases. Acta Neuropathol 2011; 121:79 - 90; http://dx.doi.org/10.1007/s00401-010-0761-3; PMID: 21058033
   PubMed Web of Science ®Google Scholar
• Zahn R. The octapeptide repeats in mammalian prion protein constitute a pH-dependent folding and aggregation site. J Mol Biol 2003; 334:477 - 88; http://dx.doi.org/10.1016/j.jmb.2003.09.048; PMID: 14623188
   PubMed Web of Science ®Google Scholar
• Miller MB, Geoghegan JC, Supattapone S. Dissociation of infectivity from seeding ability in prions with alternate docking mechanism. PLoS Pathog 2011; 7:e1002128; http://dx.doi.org/10.1371/journal.ppat.1002128; PMID: 21779169
   PubMedGoogle Scholar
• Sandberg MK, Al-Doujaily H, Sharps B, Clarke AR, Collinge J. Prion propagation and toxicity in vivo occur in two distinct mechanistic phases. Nature 2011; 470:540 - 2; http://dx.doi.org/10.1038/nature09768; PMID: 21350487
   PubMed Web of Science ®Google Scholar
• Linden R, Martins VR, Prado MA, Cammarota M, Izquierdo I, Brentani RR. Physiology of the prion protein. Physiol Rev 2008; 88:673 - 728; http://dx.doi.org/10.1152/physrev.00007.2007; PMID: 18391177
   PubMed Web of Science ®Google Scholar
• Bodrikov V, Solis GP, Stuermer CA. Prion protein promotes growth cone development through reggie/flotillin-dependent N-cadherin trafficking. J Neurosci 2011; 31:18013 - 25; http://dx.doi.org/10.1523/JNEUROSCI.4729-11.2011; PMID: 22159115
   PubMed Web of Science ®Google Scholar
• Klein C, Kramer EM, Cardine AM, Schraven B, Brandt R, Trotter J. Process outgrowth of oligodendrocytes is promoted by interaction of fyn kinase with the cytoskeletal protein tau. J Neurosci 2002; 22:698 - 707; PMID: 11826099
   PubMed Web of Science ®Google Scholar
• Crozet C, Beranger F, Lehmann S. Cellular pathogenesis in prion diseases. Vet Res 2008; 39:44; http://dx.doi.org/10.1051/vetres:2008021; PMID: 18413130
   PubMed Web of Science ®Google Scholar
• Bate C, Williams A. The cellular prion protein with a monoacylated glycosylphosphatidylinositol anchor modifies cell membranes, inhibits cell signaling and reduces prion formation. Prion 2011; 5:65 - 8; http://dx.doi.org/10.4161/pri.5.2.16095; PMID: 21738009
   PubMed Web of Science ®Google Scholar
• Barria MA, Mukherjee A, Gonzalez-Romero D, Morales R, Soto C. De novo generation of infectious prions in vitro produces a new disease phenotype. PLoS Pathog 2009; 5:e1000421; http://dx.doi.org/10.1371/journal.ppat.1000421; PMID: 19436715
   PubMed Web of Science ®Google Scholar
• Chesebro B, Race B, Meade-White K, Lacasse R, Race R, Klingeborn M, et al. Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring. PLoS Pathog 2010; 6:e1000800; http://dx.doi.org/10.1371/journal.ppat.1000800; PMID: 20221436
   PubMed Web of Science ®Google Scholar
• Chesebro B, Trifilo M, Race R, Meade-White K, Teng C, LaCasse R, et al. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 2005; 308:1435 - 9; http://dx.doi.org/10.1126/science.1110837; PMID: 15933194
   PubMed Web of Science ®Google Scholar
• Sunyach C, Jen A, Deng J, Fitzgerald KT, Frobert Y, Grassi J, et al. The mechanism of internalization of glycosylphosphatidylinositol-anchored prion protein. EMBO J 2003; 22:3591 - 601; http://dx.doi.org/10.1093/emboj/cdg344; PMID: 12853474
   PubMed Web of Science ®Google Scholar
• Mouillet-Richard S, Ermonval M, Chebassier C, Laplanche JL, Lehmann S, Launay JM, et al. Signal transduction through prion protein. Science 2000; 289:1925 - 8; http://dx.doi.org/10.1126/science.289.5486.1925; PMID: 10988071
   PubMed Web of Science ®Google Scholar
• Si K, Giustetto M, Etkin A, Hsu R, Janisiewicz AM, Miniaci MC, et al. A neuronal isoform of CPEB regulates local protein synthesis and stabilizes synapse-specific long-term facilitation in aplysia. Cell 2003; 115:893 - 904; http://dx.doi.org/10.1016/S0092-8674(03)01021-3; PMID: 14697206
   PubMed Web of Science ®Google Scholar
• Heinrich SU, Lindquist S. Protein-only mechanism induces self-perpetuating changes in the activity of neuronal Aplysia cytoplasmic polyadenylation element binding protein (CPEB). Proc Natl Acad Sci U S A 2011; 108:2999 - 3004; http://dx.doi.org/10.1073/pnas.1019368108; PMID: 21270333
   PubMed Web of Science ®Google Scholar
• Si K, Lindquist S, Kandel ER. A neuronal isoform of the aplysia CPEB has prion-like properties. Cell 2003; 115:879 - 91; http://dx.doi.org/10.1016/S0092-8674(03)01020-1; PMID: 14697205
   PubMed Web of Science ®Google Scholar
• Desplats P, Lee HJ, Bae EJ, Patrick C, Rockenstein E, Crews L, et al. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci U S A 2009; 106:13010 - 5; http://dx.doi.org/10.1073/pnas.0903691106; PMID: 19651612
   PubMed Web of Science ®Google Scholar
• Eisele YS, Obermüller U, Heilbronner G, Baumann F, Kaeser SA, Wolburg H, et al. Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis. Science 2010; 330:980 - 2; http://dx.doi.org/10.1126/science.1194516; PMID: 20966215
   PubMed Web of Science ®Google Scholar
• Emmanouilidou E, Melachroinou K, Roumeliotis T, Garbis SD, Ntzouni M, Margaritis LH, et al. Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci 2010; 30:6838 - 51; http://dx.doi.org/10.1523/JNEUROSCI.5699-09.2010; PMID: 20484626
   PubMed Web of Science ®Google Scholar
• Rajendran L, Honsho M, Zahn TR, Keller P, Geiger KD, Verkade P, et al. Alzheimer’s disease beta-amyloid peptides are released in association with exosomes. Proc Natl Acad Sci U S A 2006; 103:11172 - 7; http://dx.doi.org/10.1073/pnas.0603838103; PMID: 16837572
   PubMed Web of Science ®Google Scholar
• Lee HJ, Choi C, Lee SJ. Membrane-bound alpha-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form. J Biol Chem 2002; 277:671 - 8; http://dx.doi.org/10.1074/jbc.M107045200; PMID: 11679584
   PubMed Web of Science ®Google Scholar
• Guo JL, Lee VM. Seeding of normal Tau by pathological Tau conformers drives pathogenesis of Alzheimer-like tangles. J Biol Chem 2011; 286:15317 - 31; http://dx.doi.org/10.1074/jbc.M110.209296; PMID: 21372138
   PubMed Web of Science ®Google Scholar
• Corsetti V, Amadoro G, Gentile A, Capsoni S, Ciotti MT, Cencioni MT, et al. Identification of a caspase-derived N-terminal tau fragment in cellular and animal Alzheimer’s disease models. Mol Cell Neurosci 2008; 38:381 - 92; http://dx.doi.org/10.1016/j.mcn.2008.03.011; PMID: 18511295
   PubMed Web of Science ®Google Scholar
• Binder LI, Frankfurter A, Rebhun LI. The distribution of tau in the mammalian central nervous system. J Cell Biol 1985; 101:1371 - 8; http://dx.doi.org/10.1083/jcb.101.4.1371; PMID: 3930508
   PubMed Web of Science ®Google Scholar
• Lindwall G, Cole RD. Phosphorylation affects the ability of tau protein to promote microtubule assembly. J Biol Chem 1984; 259:5301 - 5; PMID: 6425287
   PubMed Web of Science ®Google Scholar
• Drechsel DN, Hyman AA, Cobb MH, Kirschner MW. Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau. Mol Biol Cell 1992; 3:1141 - 54; PMID: 1421571
   PubMed Web of Science ®Google Scholar
• Caceres A, Kosik KS. Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons. Nature 1990; 343:461 - 3; http://dx.doi.org/10.1038/343461a0; PMID: 2105469
   PubMed Web of Science ®Google Scholar
• Brandt R, Léger J, Lee G. Interaction of tau with the neural plasma membrane mediated by tau’s amino-terminal projection domain. J Cell Biol 1995; 131:1327 - 40; http://dx.doi.org/10.1083/jcb.131.5.1327; PMID: 8522593
   PubMed Web of Science ®Google Scholar
• Lee G, Newman ST, Gard DL, Band H, Panchamoorthy G. Tau interacts with src-family non-receptor tyrosine kinases. J Cell Sci 1998; 111:3167 - 77; PMID: 9763511
   PubMed Web of Science ®Google Scholar
• Belkadi A, LoPresti P. Truncated Tau with the Fyn-binding domain and without the microtubule-binding domain hinders the myelinating capacity of an oligodendrocyte cell line. J Neurochem 2008; 107:351 - 60; http://dx.doi.org/10.1111/j.1471-4159.2008.05600.x; PMID: 18680553
   PubMed Web of Science ®Google Scholar
• Zmuda JF, Rivas RJ. Actin disruption alters the localization of tau in the growth cones of cerebellar granule neurons. J Cell Sci 2000; 113:2797 - 809; PMID: 10893194
   PubMed Web of Science ®Google Scholar
• Sverdlov M, Shajahan AN, Minshall RD. Tyrosine phosphorylation-dependence of caveolae-mediated endocytosis. J Cell Mol Med 2007; 11:1239 - 50; http://dx.doi.org/10.1111/j.1582-4934.2007.00127.x; PMID: 18205698
   PubMed Web of Science ®Google Scholar
• Hall GF, Yao J, Lee G. Human tau becomes phosphorylated and forms filamentous deposits when overexpressed in lamprey central neurons in situ. Proc Natl Acad Sci U S A 1997; 94:4733 - 8; http://dx.doi.org/10.1073/pnas.94.9.4733; PMID: 9114060
   PubMed Web of Science ®Google Scholar
• Hall GF, Chu B, Lee G, Yao J. Human tau filaments induce microtubule and synapse loss in an in vivo model of neurofibrillary degenerative disease. J Cell Sci 2000; 113:1373 - 87; PMID: 10725221
   PubMed Web of Science ®Google Scholar
• Hall GF, Lee VM, Lee G, Yao J. Staging of neurofibrillary degeneration caused by human tau overexpression in a unique cellular model of human tauopathy. Am J Pathol 2001; 158:235 - 46; http://dx.doi.org/10.1016/S0002-9440(10)63962-4; PMID: 11141497
   PubMed Web of Science ®Google Scholar
• Honson NS, Jensen JR, Abraha A, Hall GF, Kuret J. Small-molecule mediated neuroprotection in an in situ model of tauopathy. Neurotox Res 2009; 15:274 - 83; http://dx.doi.org/10.1007/s12640-009-9028-y; PMID: 19384600
   PubMed Web of Science ®Google Scholar
• Gómez-Ramos A, Díaz-Hernández M, Rubio A, Miras-Portugal MT, Avila J. Extracellular tau promotes intracellular calcium increase through M1 and M3 muscarinic receptors in neuronal cells. Mol Cell Neurosci 2008; 37:673 - 81; http://dx.doi.org/10.1016/j.mcn.2007.12.010; PMID: 18272392
   PubMed Web of Science ®Google Scholar
• Iliev AI, Ganesan S, Bunt G, Wouters FS. Removal of pattern-breaking sequences in microtubule binding repeats produces instantaneous tau aggregation and toxicity. J Biol Chem 2006; 281:37195 - 204; http://dx.doi.org/10.1074/jbc.M604863200; PMID: 17008320
   PubMed Web of Science ®Google Scholar
• Mocanu MM, Nissen A, Eckermann K, Khlistunova I, Biernat J, Drexler D, et al. The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy. J Neurosci 2008; 28:737 - 48; http://dx.doi.org/10.1523/JNEUROSCI.2824-07.2008; PMID: 18199773
   PubMed Web of Science ®Google Scholar
• Arima K. Ultrastructural characteristics of tau filaments in tauopathies: immuno-electron microscopic demonstration of tau filaments in tauopathies. Neuropathology 2006; 26:475 - 83; http://dx.doi.org/10.1111/j.1440-1789.2006.00669.x; PMID: 17080728
   PubMed Web of Science ®Google Scholar
• van Eersel J, Bi M, Ke YD, Hodges JR, Xuereb JH, Gregory GC, et al. Phosphorylation of soluble tau differs in Pick’s disease and Alzheimer’s disease brains. J Neural Transm 2009; 116:1243 - 51; http://dx.doi.org/10.1007/s00702-009-0293-y; PMID: 19693433
   PubMed Web of Science ®Google Scholar
• Sergeant N, Wattez A, Delacourte A. Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively “exon 10” isoforms. J Neurochem 1999; 72:1243 - 9; http://dx.doi.org/10.1046/j.1471-4159.1999.0721243.x; PMID: 10037497
   PubMed Web of Science ®Google Scholar
• Chirita CN, Necula M, Kuret J. Anionic micelles and vesicles induce tau fibrillization in vitro. J Biol Chem 2003; 278:25644 - 50; http://dx.doi.org/10.1074/jbc.M301663200; PMID: 12730214
   PubMed Web of Science ®Google Scholar
• Díaz-Nido J, Wandosell F, Avila J. Glycosaminoglycans and beta-amyloid, prion and tau peptides in neurodegenerative diseases. Peptides 2002; 23:1323 - 32; http://dx.doi.org/10.1016/S0196-9781(02)00068-2; PMID: 12128089
   PubMed Web of Science ®Google Scholar
• Alonso AD, Grundke-Iqbal I, Barra HS, Iqbal K. Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau. Proc Natl Acad Sci U S A 1997; 94:298 - 303; http://dx.doi.org/10.1073/pnas.94.1.298; PMID: 8990203
   PubMed Web of Science ®Google Scholar
• Park SY, Ferreira A. The generation of a 17 kDa neurotoxic fragment: an alternative mechanism by which tau mediates beta-amyloid-induced neurodegeneration. J Neurosci 2005; 25:5365 - 75; http://dx.doi.org/10.1523/JNEUROSCI.1125-05.2005; PMID: 15930385
   PubMed Web of Science ®Google Scholar
• Amadoro G, Ciotti MT, Costanzi M, Cestari V, Calissano P, Canu N. NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK/MAPK activation. Proc Natl Acad Sci U S A 2006; 103:2892 - 7; http://dx.doi.org/10.1073/pnas.0511065103; PMID: 16477009
   PubMed Web of Science ®Google Scholar
• King ME, Kan HM, Baas PW, Erisir A, Glabe CG, Bloom GS. Tau-dependent microtubule disassembly initiated by prefibrillar beta-amyloid. J Cell Biol 2006; 175:541 - 6; http://dx.doi.org/10.1083/jcb.200605187; PMID: 17101697
   PubMed Web of Science ®Google Scholar
• Rapoport M, Dawson HN, Binder LI, Vitek MP, Ferreira A. Tau is essential to beta -amyloid-induced neurotoxicity. Proc Natl Acad Sci U S A 2002; 99:6364 - 9; http://dx.doi.org/10.1073/pnas.092136199; PMID: 11959919
   PubMed Web of Science ®Google Scholar
• Wang YP, Biernat J, Pickhardt M, Mandelkow E, Mandelkow EM. Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model. Proc Natl Acad Sci U S A 2007; 104:10252 - 7; http://dx.doi.org/10.1073/pnas.0703676104; PMID: 17535890
   PubMed Web of Science ®Google Scholar
• Zilka N, Filipcik P, Koson P, Fialova L, Skrabana R, Zilkova M, et al. Truncated tau from sporadic Alzheimer’s disease suffices to drive neurofibrillary degeneration in vivo. FEBS Lett 2006; 580:3582 - 8; http://dx.doi.org/10.1016/j.febslet.2006.05.029; PMID: 16753151
   PubMed Web of Science ®Google Scholar
• Baum L, Seger R, Woodgett JR, Kawabata S, Maruyama K, Koyama M, et al. Overexpressed tau protein in cultured cells is phosphorylated without formation of PHF: implication of phosphoprotein phosphatase involvement. Brain Res Mol Brain Res 1995; 34:1 - 17; http://dx.doi.org/10.1016/0169-328X(95)00111-5; PMID: 8750856
   PubMedGoogle Scholar
• Merrick SE, Demoise DC, Lee VM. Site-specific dephosphorylation of tau protein at Ser202/Thr205 in response to microtubule depolymerization in cultured human neurons involves protein phosphatase 2A. J Biol Chem 1996; 271:5589 - 94; http://dx.doi.org/10.1074/jbc.271.10.5589; PMID: 8621419
   PubMed Web of Science ®Google Scholar
• Ishihara T, Hong M, Zhang B, Nakagawa Y, Lee MK, Trojanowski JQ, et al. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron 1999; 24:751 - 62; http://dx.doi.org/10.1016/S0896-6273(00)81127-7; PMID: 10595524
   PubMed Web of Science ®Google Scholar
• Spittaels K, Van den Haute C, Van Dorpe J, Bruynseels K, Vandezande K, Laenen I, et al. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. Am J Pathol 1999; 155:2153 - 65; http://dx.doi.org/10.1016/S0002-9440(10)65533-2; PMID: 10595944
   PubMed Web of Science ®Google Scholar
• Hall GF, Yao J. Modeling tauopathy: a range of complementary approaches. Biochim Biophys Acta 2005; 1739:224 - 39; PMID: 15615641
   PubMed Web of Science ®Google Scholar
• Simón D, García-García E, Royo F, Falcón-Pérez JM, Avila J. Proteostasis of tau. Tau overexpression results in its secretion via membrane vesicles. FEBS Lett 2012; 586:47 - 54; http://dx.doi.org/10.1016/j.febslet.2011.11.022; PMID: 22138183
   PubMed Web of Science ®Google Scholar
• Götz J, Probst A, Spillantini MG, Schäfer T, Jakes R, Bürki K, et al. Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform. EMBO J 1995; 14:1304 - 13; PMID: 7729409
   PubMed Web of Science ®Google Scholar
• Brion JP, Tremp G, Octave JN. Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer’s disease. Am J Pathol 1999; 154:255 - 70; http://dx.doi.org/10.1016/S0002-9440(10)65272-8; PMID: 9916940
   PubMed Web of Science ®Google Scholar
• Lewis J, McGowan E, Rockwood J, Melrose H, Nacharaju P, Van Slegtenhorst M, et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet 2000; 25:402 - 5; http://dx.doi.org/10.1038/78078; PMID: 10932182
   PubMed Web of Science ®Google Scholar
• Busciglio J, Lorenzo A, Yeh J, Yankner BA. beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 1995; 14:879 - 88; http://dx.doi.org/10.1016/0896-6273(95)90232-5; PMID: 7718249
   PubMed Web of Science ®Google Scholar
• Hong M, Zhukareva V, Vogelsberg-Ragaglia V, Wszolek Z, Reed L, Miller BI, et al. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 1998; 282:1914 - 7; http://dx.doi.org/10.1126/science.282.5395.1914; PMID: 9836646
   PubMed Web of Science ®Google Scholar
• Nacharaju P, Lewis J, Easson C, Yen S, Hackett J, Hutton M, et al. Accelerated filament formation from tau protein with specific FTDP-17 missense mutations. FEBS Lett 1999; 447:195 - 9; http://dx.doi.org/10.1016/S0014-5793(99)00294-X; PMID: 10214944
   PubMed Web of Science ®Google Scholar
• Nickel W. Unconventional secretory routes: direct protein export across the plasma membrane of mammalian cells. Traffic 2005; 6:607 - 14; http://dx.doi.org/10.1111/j.1600-0854.2005.00302.x; PMID: 15998317
   PubMed Web of Science ®Google Scholar
• van Harten AC, Kester MI, Visser PJ, Blankenstein MA, Pijnenburg YA, van der Flier WM, et al. Tau and p-tau as CSF biomarkers in dementia: a meta-analysis. Clin Chem Lab Med 2011; 49:353 - 66; http://dx.doi.org/10.1515/cclm.2011.086; PMID: 21342021
   PubMed Web of Science ®Google Scholar
• Johnson GV, Seubert P, Cox TM, Motter R, Brown JP, Galasko D. The tau protein in human cerebrospinal fluid in Alzheimer’s disease consists of proteolytically derived fragments. J Neurochem 1997; 68:430 - 3; http://dx.doi.org/10.1046/j.1471-4159.1997.68010430.x; PMID: 8978756
   PubMed Web of Science ®Google Scholar
• Schiess MC, Barnes JL, Ellmore TM, Poindexter BJ, Dinh K, Bick RJ. CSF from Parkinson disease patients differentially affects cultured microglia and astrocytes. BMC Neurosci 2010; 11:151; PMID: 21114836
   PubMed Web of Science ®Google Scholar
• Diaz-Espinoza R, Soto C. Generation of prions in vitro and the protein-only hypothesis. Prion 2010; 4:53 - 9; http://dx.doi.org/10.4161/pri.4.2.11960; PMID: 20448454
   PubMed Web of Science ®Google Scholar
• Ryou C, Mays CE. Prion propagation in vitro: are we there yet?. Int J Med Sci 2008; 5:347 - 53; http://dx.doi.org/10.7150/ijms.5.347; PMID: 19015743
   PubMedGoogle Scholar
• Graham JF, Agarwal S, Kurian D, Kirby L, Pinheiro TJ, Gill AC. Low density subcellular fractions enhance disease-specific prion protein misfolding. J Biol Chem 2010; 285:9868 - 80; http://dx.doi.org/10.1074/jbc.M109.093484; PMID: 20106973
   PubMed Web of Science ®Google Scholar
• Wang XF, Dong CF, Zhang J, Wan YZ, Li F, Huang YX, et al. Human tau protein forms complex with PrP and some GSS- and fCJD-related PrP mutants possess stronger binding activities with tau in vitro. Mol Cell Biochem 2008; 310:49 - 55; http://dx.doi.org/10.1007/s11010-007-9664-6; PMID: 18038270
   PubMed Web of Science ®Google Scholar
• Lawson VA, Klemm HM, Welton JM, Masters CL, Crouch P, Cappai R, et al. Gene knockout of tau expression does not contribute to the pathogenesis of prion disease. J Neuropathol Exp Neurol 2011; 70:1036 - 45; http://dx.doi.org/10.1097/NEN.0b013e318235b471; PMID: 22002429
   PubMed Web of Science ®Google Scholar
• Canu N, Filesi I, Pristerà A, Ciotti MT, Biocca S. Altered intracellular distribution of PrP(C) and impairment of proteasome activity in tau overexpressing cortical neurons. J Alzheimers Dis 2011; 27:603 - 13; PMID: 21841253
   PubMed Web of Science ®Google Scholar
• Lee S, Jung C, Lee G, Hall GF. Exonic point mutations of human tau enhance its toxicity and cause characteristic changes in neuronal morphology, tau distribution and tau phosphorylation in the lamprey cellular model of tauopathy. J Alzheimers Dis 2009; 16:99 - 111; PMID: 19158426
   PubMed Web of Science ®Google Scholar
• Caughey B, Baron GS, Chesebro B, Jeffrey M. Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions. Annu Rev Biochem 2009; 78:177 - 204; http://dx.doi.org/10.1146/annurev.biochem.78.082907.145410; PMID: 19231987
   PubMed Web of Science ®Google Scholar
• Santuccione A, Sytnyk V, Leshchyns’ka I, Schachner M. Prion protein recruits its neuronal receptor NCAM to lipid rafts to activate p59fyn and to enhance neurite outgrowth. J Cell Biol 2005; 169:341 - 54; http://dx.doi.org/10.1083/jcb.200409127; PMID: 15851519
   PubMed Web of Science ®Google Scholar
• Bizat N, Peyrin JM, Haïk S, Cochois V, Beaudry P, Laplanche JL, et al. Neuron dysfunction is induced by prion protein with an insertional mutation via a Fyn kinase and reversed by sirtuin activation in Caenorhabditis elegans. J Neurosci 2010; 30:5394 - 403; http://dx.doi.org/10.1523/JNEUROSCI.5831-09.2010; PMID: 20392961
   PubMed Web of Science ®Google Scholar
• Fevrier B, Vilette D, Archer F, Loew D, Faigle W, Vidal M, et al. Cells release prions in association with exosomes. Proc Natl Acad Sci U S A 2004; 101:9683 - 8; http://dx.doi.org/10.1073/pnas.0308413101; PMID: 15210972
   PubMed Web of Science ®Google Scholar
• Vella LJ, Sharples RA, Lawson VA, Masters CL, Cappai R, Hill AF. Packaging of prions into exosomes is associated with a novel pathway of PrP processing. J Pathol 2007; 211:582 - 90; http://dx.doi.org/10.1002/path.2145; PMID: 17334982
   PubMed Web of Science ®Google Scholar
• Fang Y, Wu N, Gan X, Yan W, Morrell JC, Gould SJ. Higher-order oligomerization targets plasma membrane proteins and HIV gag to exosomes. PLoS Biol 2007; 5:e158; http://dx.doi.org/10.1371/journal.pbio.0050158; PMID: 17550307
   PubMed Web of Science ®Google Scholar
• Nunziante M, Ackermann K, Dietrich K, Wolf H, Gädtke L, Gilch S, et al. Proteasomal dysfunction and endoplasmic reticulum stress enhance trafficking of prion protein aggregates through the secretory pathway and increase accumulation of pathologic prion protein. J Biol Chem 2011; 286:33942 - 53; http://dx.doi.org/10.1074/jbc.M111.272617; PMID: 21835918
   PubMed Web of Science ®Google Scholar
• Gadad BS, Britton GB, Rao KS. Targeting oligomers in neurodegenerative disorders: lessons from α-synuclein, tau, and amyloid-β peptide. J Alzheimers Dis 2011; 24:Suppl 2 223 - 32; PMID: 21460436
   PubMed Web of Science ®Google Scholar
• Deleault NR, Lucassen RW, Supattapone S. RNA molecules stimulate prion protein conversion. Nature 2003; 425:717 - 20; http://dx.doi.org/10.1038/nature01979; PMID: 14562104
   PubMed Web of Science ®Google Scholar
• Kampers T, Friedhoff P, Biernat J, Mandelkow EM, Mandelkow E. RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments. FEBS Lett 1996; 399:344 - 9; http://dx.doi.org/10.1016/S0014-5793(96)01386-5; PMID: 8985176
   PubMed Web of Science ®Google Scholar
• Zehe C, Engling A, Wegehingel S, Schäfer T, Nickel W. Cell-surface heparan sulfate proteoglycans are essential components of the unconventional export machinery of FGF-2. Proc Natl Acad Sci U S A 2006; 103:15479 - 84; http://dx.doi.org/10.1073/pnas.0605997103; PMID: 17030799
   PubMed Web of Science ®Google Scholar
• Peters PJ, Mironov A Jr., Peretz D, van Donselaar E, Leclerc E, Erpel S, et al. Trafficking of prion proteins through a caveolae-mediated endosomal pathway. J Cell Biol 2003; 162:703 - 17; http://dx.doi.org/10.1083/jcb.200304140; PMID: 12925711
   PubMed Web of Science ®Google Scholar
• Kremer A, Maurin H, Demedts D, Devijver H, Borghgraef P, Van Leuven F. Early improved and late defective cognition is reflected by dendritic spines in Tau.P301L mice. J Neurosci 2011; 31:18036 - 47; http://dx.doi.org/10.1523/JNEUROSCI.4859-11.2011; PMID: 22159117
   PubMed Web of Science ®Google Scholar
• Boekhoorn K, Terwel D, Biemans B, Borghgraef P, Wiegert O, Ramakers GJ, et al. Improved long-term potentiation and memory in young tau-P301L transgenic mice before onset of hyperphosphorylation and tauopathy. J Neurosci 2006; 26:3514 - 23; http://dx.doi.org/10.1523/JNEUROSCI.5425-05.2006; PMID: 16571759
   PubMed Web of Science ®Google Scholar
• Tackenberg C, Brandt R. Divergent pathways mediate spine alterations and cell death induced by amyloid-beta, wild-type tau, and R406W tau. J Neurosci 2009; 29:14439 - 50; http://dx.doi.org/10.1523/JNEUROSCI.3590-09.2009; PMID: 19923278
   PubMed Web of Science ®Google Scholar
• Perrin RJ, Woods WS, Clayton DF, George JM. Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins. J Biol Chem 2001; 276:41958 - 62; http://dx.doi.org/10.1074/jbc.M105022200; PMID: 11553616
   PubMed Web of Science ®Google Scholar
• Sluchanko NN, Gusev NB. Probable participation of 14-3-3 in tau protein oligomerization and aggregation. J Alzheimers Dis 2011; 27:467 - 76; PMID: 21876254
   PubMed Web of Science ®Google Scholar
• Waxman EA, Giasson BI. Induction of intracellular tau aggregation is promoted by α-synuclein seeds and provides novel insights into the hyperphosphorylation of tau. J Neurosci 2011; 31:7604 - 18; http://dx.doi.org/10.1523/JNEUROSCI.0297-11.2011; PMID: 21613474
   PubMed Web of Science ®Google Scholar
• Whitwell JL, Jack CR Jr., Parisi JE, Knopman DS, Boeve BF, Petersen RC, et al. Rates of cerebral atrophy differ in different degenerative pathologies. Brain 2007; 130:1148 - 58; http://dx.doi.org/10.1093/brain/awm021; PMID: 17347250
   PubMed Web of Science ®Google Scholar
• Esposito A, Dohm CP, Kermer P, Bähr M, Wouters FS. alpha-Synuclein and its disease-related mutants interact differentially with the microtubule protein tau and associate with the actin cytoskeleton. Neurobiol Dis 2007; 26:521 - 31; http://dx.doi.org/10.1016/j.nbd.2007.01.014; PMID: 17408955
   PubMed Web of Science ®Google Scholar
• Chen C, Shi Q, Zhang BY, Wang GR, Zhou W, Gao C, et al. The prepared tau exon-specific antibodies revealed distinct profiles of tau in CSF of the patients with Creutzfeldt-Jakob disease. PLoS One 2010; 5:e11886; http://dx.doi.org/10.1371/journal.pone.0011886; PMID: 20686702
   PubMed Web of Science ®Google Scholar
• Lasagna-Reeves CA, Castillo-Carranza DL, Guerrero-Muoz MJ, Jackson GR, Kayed R. Preparation and characterization of neurotoxic tau oligomers. Biochemistry 2010; 49:10039 - 41; http://dx.doi.org/10.1021/bi1016233; PMID: 21047142
   PubMed Web of Science ®Google Scholar
• Terwel D, Lasrado R, Snauwaert J, Vandeweert E, Van Haesendonck C, Borghgraef P, et al. Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R/2N transgenic mice. J Biol Chem 2005; 280:3963 - 73; http://dx.doi.org/10.1074/jbc.M409876200; PMID: 15509565
   PubMed Web of Science ®Google Scholar
• Liu L, Drouet V, Wu JW, Witter MP, Small SA, Clelland C, et al. Trans-synaptic spread of tau pathology in vivo. PLoS One 2012; 7:e31302; http://dx.doi.org/10.1371/journal.pone.0031302; PMID: 22312444
   PubMed Web of Science ®Google Scholar
• Alais S, Simoes S, Baas D, Lehmann S, Raposo G, Darlix JL, et al. Mouse neuroblastoma cells release prion infectivity associated with exosomal vesicles. Biol Cell 2008; 100:603 - 15; http://dx.doi.org/10.1042/BC20080025; PMID: 18422484
   PubMed Web of Science ®Google Scholar
• Veith NM, Plattner H, Stuermer CA, Schulz-Schaeffer WJ, Bürkle A. Immunolocalisation of PrPSc in scrapie-infected N2a mouse neuroblastoma cells by light and electron microscopy. Eur J Cell Biol 2009; 88:45 - 63; http://dx.doi.org/10.1016/j.ejcb.2008.08.001; PMID: 18834644
   PubMed Web of Science ®Google Scholar
• Estes PS, Boehringer A, Zwick R, Tang JE, Grigsby B, Zarnescu DC. Wild-type and A315T mutant TDP-43 exert differential neurotoxicity in a Drosophila model of ALS. Hum Mol Genet 2011; 20:2308 - 21; http://dx.doi.org/10.1093/hmg/ddr124; PMID: 21441568
   PubMed Web of Science ®Google Scholar